American pharmaceutical giant Johnson & Johnson (JNJ) is boosting its U.S. investments by 25% to more than $55 billion over the next four

We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against the other best pharma stocks to buy according to hedge funds.

Johnson & Johnson said it is increasing U.S investments to more than $55 billion over the next four years, boosting spending on manufacturing, R&D and technology.